Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00944
Species: Homo sapiens
Position : chr13:73880413-74042621
Year: 2016
Title: Identification of focally amplified lineage-specific super-enhancers in human epithelial cancers.
Genome Build: hg19
Enhancer Type: Super-enhancer
Condition: Disease
Disease Name: lung adenocarcinoma
PMID:  26656844
MONDO: MONDO:0005061
Tissue: lung
Tissue Ontology ID: UBERON:0002048
Cell Source: Esophageal Carcinoma
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Enhancer activity assay; TF-binding/chromatin assay; Chromatin interaction assay; Endogenous enhancer perturbation; In vivo functional validation; Disease-associated enhancer analysis
High Throughput Method: ChIP-seq
Low Throughput Method: Luciferase reporter assay; Reporter assay; CRISPR-Cas9 targeted editing/deletion; ChIP-qPCR/ChIP; 3C; RT-qPCR/qPCR; RNAi/siRNA/shRNA
About Target Gene
Target gene : KLF5
About TF
TF name : CEBPB
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
CEBPB C-MYB transcription factor network pid 87
CEBPB EGFR1 netpath 475
CEBPB FOXA1 transcription factor network pid 45
CEBPB FOXA2 and FOXA3 transcription factor networks pid 45
CEBPB IFN-gamma pathway pid 43
CEBPB IL3-mediated signaling events pid 27
CEBPB IL4-mediated signaling events pid 66
CEBPB IL4 netpath 75
CEBPB IL6-mediated signaling events pid 48
CEBPB IL6 netpath 85
CEBPB RANKL netpath 84
CEBPB Regulation of nuclear SMAD2/3 signaling pid 82
CEBPB Regulation of retinoblastoma protein pid 67
CEBPB Senescence-Associated Secretory Phenotype (SASP) reactome 108
CEBPB Signaling mediated by p38-alpha and p38-beta pid 35
CEBPB TCR netpath 261
CEBPB Transcriptional regulation of white adipocyte differentiation reactome 79
CEBPB Validated nuclear estrogen receptor alpha network pid 65
CEBPB Hs_Senescence_and_Autophagy_in_Cancer_WP615_81193 wikipathways 62
CEBPB Hs_Oncostatin_M_Signaling_Pathway_WP2374_73668 wikipathways 44
CEBPB Hs_Transcriptional_activation_by_NRF2_WP3_79527 wikipathways 6
CEBPB Hs_Lung_fibrosis_WP3624_91475 wikipathways 23
CEBPB Hs_IL17_signaling_pathway_WP2112_89838 wikipathways 20
Enhancer Associated Network
Overlapping Enhancers (hg19) 14 found
Enhancer ID Position Tissue Cell Disease
E_00945 chr13:73880413-74042621 lung malignant cell lung adenocarcinoma
E_00978 chr13:73880690-73990596 NA malignant cell Esophageal Carcinoma
E_01076 chr13:73941969-73943506 head and neck epithelium malignant cell head and neck squamous cell carcinoma
E_01079 chr13:73941969-74004429 head and neck epithelium malignant cell head and neck squamous cell carcinoma
E_00004 chr13:73958961-73960160 colon malignant cell colorectal adenocarcinoma
E_00005 chr13:73958961-73960160 colon malignant cell colorectal adenocarcinoma
E_00006 chr13:73958961-73960160 colon malignant cell colorectal adenocarcinoma
E_00007 chr13:73958961-73960160 colon malignant cell colorectal adenocarcinoma
E_01077 chr13:73995211-73996254 head and neck epithelium malignant cell head and neck squamous cell carcinoma
E_01078 chr13:74002153-74004429 head and neck epithelium malignant cell head and neck squamous cell carcinoma
E_01331 chr13:74003796-74004073 colon malignant cell colorectal cancer
E_01332 chr13:74003796-74004073 colon malignant cell colorectal cancer
E_01333 chr13:74003796-74004073 colon malignant cell colorectal cancer
E_01408 chr13:74003796-74004073 colon malignant cell colorectal cancer
Expression of Target Genes for the Enhancer